Boost Biopharma’s innovative Rapid Antigen Deployment (RAD) Process enables the rapid generation of protein subunit vaccine antigens and monoclonal antibodies. The company has developed vaccines for a wide range of pathogens of global importance, including SARS-CoV-2, Dengue virus, Zika virus, West Nile virus, and Japanese Encephalitis, with other vaccines and antibodies in development.
Boost is collaborating with biopharmaceutical firms globally, including companies with existing approved and marketed vaccines. We offer single vaccine licenses, access to our inventory of antigens for commercial development, and prioritized access.
Company Details
- Employees
- 4
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.boostbiopharma.com/
Boost Biopharma, Inc. Questions
Boost Biopharma, Inc.'s website is https://www.boostbiopharma.com/
Boost Biopharma, Inc.'s LinkedIn profile is https://www.linkedin.com/company/boost-biopharma
Boost Biopharma, Inc. has
4 employees.
View email and phone details for 4
employees at Boost Biopharma, Inc..
Boost Biopharma, Inc.'s industry is
Biotechnology Research
Boost Biopharma, Inc.'s top competitors are
Arnav Biotech,
Adjane,
Eenzyme, Llc,
Immunewatch,
Vaccine Equity Education Coalition,
Adjuvax Llc,
Comet Therapeutics,
Iscope Concussion & Pain Clinics,
Baiyaphytopharm,
Chrysaor Biologics.
Boost Biopharma, Inc.'s categories are Biotechnology Research
